Estabrook Capital Management’s Intellia Therapeutics NTLA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-14
| Closed | -$488 | – | 406 |
|
|
2022
Q4 | $488 | Hold |
14
| – | – | ﹤0.01% | 412 |
|
|
2022
Q3 | $783 | Hold |
14
| – | – | ﹤0.01% | 400 |
|
|
2022
Q2 | $725 | Hold |
14
| – | – | ﹤0.01% | 410 |
|
|
2022
Q1 | $1.02K | Hold |
14
| – | – | ﹤0.01% | 404 |
|
|
2021
Q4 | $1.66K | Hold |
14
| – | – | ﹤0.01% | 420 |
|
|
2021
Q3 | $1.88K | Hold |
14
| – | – | ﹤0.01% | 300 |
|
|
2021
Q2 | $2.27K | Hold |
14
| – | – | ﹤0.01% | 297 |
|
|
2021
Q1 | $1.12K | Hold |
14
| – | – | ﹤0.01% | 309 |
|
|
2020
Q4 | $762 | Hold |
14
| – | – | ﹤0.01% | 319 |
|
|
2020
Q3 | $278 | Hold |
14
| – | – | ﹤0.01% | 315 |
|
|
2020
Q2 | $294 | Hold |
14
| – | – | ﹤0.01% | 325 |
|
|
2020
Q1 | $171 | Hold |
14
| – | – | ﹤0.01% | 328 |
|
|
2019
Q4 | $205 | Buy |
+14
| New | +$205 | ﹤0.01% | 335 |
|